BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 9005985)

  • 1. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
    Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
    J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines induce eosinophil degranulation through CCR-3.
    Fujisawa T; Kato Y; Nagase H; Atsuta J; Terada A; Iguchi K; Kamiya H; Morita Y; Kitaura M; Kawasaki H; Yoshie O; Hirai K
    J Allergy Clin Immunol; 2000 Sep; 106(3):507-13. PubMed ID: 10984371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.
    Bonecchi R; Polentarutti N; Luini W; Borsatti A; Bernasconi S; Locati M; Power C; Proudfoot A; Wells TN; Mackay C; Mantovani A; Sozzani S
    J Immunol; 1999 Jan; 162(1):474-9. PubMed ID: 9886422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
    Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
    J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.
    Tiffany HL; Alkhatib G; Combadiere C; Berger EA; Murphy PM
    J Immunol; 1998 Feb; 160(3):1385-92. PubMed ID: 9570558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
    Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
    J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
    Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
    Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
    J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
    Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
    J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
    Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
    Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.